CTRI/2018/04/013319招募中4 期
An Observational, Practice based, Open label, Prospective Non Comparative, Multicenter, Post Marketing Surveillance Study to Assess Safety and Tolerability of Minocycline Hydrochloride 100 mg Intravenous (I.V.) Injection in Indian Patients with Multi-Drug Resistant Gram (MDR) Negative Bacterial Infections.
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- Cipla Ltd
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Written signed and dated informed consent (patient or LAR)
- •2. Either gender with age 18 years and above
- •3. Patients with Multi-Drug Resistant (MDR) gram negative bacterial infection
- •4. Documented bacteriological infection susceptible to Minocycline Hydrochloride.
排除标准
- •1. Known hypersensitivity to Minocycline Hydrochloride or any of its components
- •2. Patient unsuitable to participate in the study as per the discretion of investigator
- •3. Pregnant or nursing females
- •4. Any other condition in the opinion of the investigator would affect the safety of the patient if Minocycline Hydrochloride is administered.
研究者
相似试验
招募中
4 期
An observational study to evaluate the safety and tolerability of Amphotericin B Lipid suspension in patients with Invasive Fungal Infections.CTRI/2017/08/009429Cipla Ltd
招募中
4 期
An Observational Post Marketing study to check the Safety and Effectiveness of Sofosbuvir based treatment in Patients with Chronic Hepatitis CCTRI/2017/08/009547Cipla Ltd
招募中
4 期
To monitor the safety, tolerability and efficacy of Pirfenidone in IdiopathicPulmonary FibrosisCTRI/2012/05/002707Cipla Ltd150
进行中(未招募)
4 期
This is a research study to check how safe and tolerable Bosentan on patients of Pulmonary arterial hypertension (Increase in pressure of blood vessels of the lungs).CTRI/2022/04/042308Cipla Ltd
已完成
4 期
This is a research study to check how safe and effective is Theoasthalin/ Theoasthalin forte tablets in patients with asthma and other chronic lung diseases.CTRI/2020/01/023000Cipla Ltd168
